TOP - August 2019, Vol 12, No 3

This section provides a brief overview of new cancer drugs or new indications approved by the FDA between June 10 and July 3, 2019. Read More ›

Skin cancer is the most frequently diagnosed malignancy in the United States. Although invasive melanoma comprises approximately 1% of skin cancers, it is the cause of a vast majority of skin cancer–related deaths. The following provides helpful information related to this malignancy. Read More ›

Genetic alterations in molecular pathways are involved in tumor development, survival, and progression. Read More ›

Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that uses a patient’s own genetically modified T-cells to fight cancer. Read More ›